An Observational Study of Tarceva (Erlotinib) in Participants With Locally Advanced or Metastatic Adenocarcinoma Non-Small Cell Lung Cancer (ELEMENT)

Clinical trial NCT01836133 · COMPLETED

Trial details

NCT number: NCT01836133
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Non-Squamous Non-Small Cell Lung Cancer

Start date: 2013-05-01
Primary completion: 2016-01-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.